Regeneron Pharmaceuticals REGN Income Statements

Conto economico

Quarter End	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	3,42B	3,16B	3,16B	3,36B	3,43B	3,15B	3,55B	3,72B
Reddito operativo	1,05B	946,7M	1,02B	1,11B	972,9M	751,4M	1,07B	1,18B
Reddito ante imposte	1,32B	858M	1,08B	1,11B	1,15B	700,7M	1,63B	1,49B
Reddito netto	1,2B	817,8M	968,4M	1,01B	1,16B	722M	1,43B	1,34B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	1,1B	876M	1,03B	1,13B	920,7M	751,5M	1,07B	1,18B
EBITDA	1,15B	1,05B	1,12B	1,22B	1,09B	865,5M	1,19B	1,3B

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	4,86B	5,87B	6,71B	7,86B	8,78B	16,12B	12,26B	13,12B
Reddito operativo	1,33B	2,08B	2,53B	2,21B	3,58B	8,95B	4,74B	4,05B
Reddito ante imposte	1,33B	2,08B	2,55B	2,43B	3,81B	9,33B	4,86B	4,2B
Reddito netto	895,52M	1,2B	2,44B	2,12B	3,51B	8,08B	4,34B	3,95B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	4.178	5.324	10.705	9.492	16.246	36.757	19.582	17.951
UTILE OPERATIVO	1,34B	2,1B	2,58B	2,34B	3,67B	9B	4,8B	4,03B
EBITDA	1,44B	2,22B	2,68B	2,42B	3,81B	9,23B	5,08B	4,47B